Bone Biologics Corp (BBLG) stock
BBLGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$0.29−0.02 (-5.92%)
Close on Nov 18, 2026Market cap $986.22KP/E –Yield –
Bone Biologics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Bone Biologics's shares outstanding was 4M at Sep 30, 2026. For fiscal 2025 it was 1M, up 364.4% from the year before. Over ten years it grew 73.5% a year on average. The highest annual figure on record is 1M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1M | +364.4% |
| FY2024 | Dec 31, 2024 | 0M | -3.9% |
| FY2023 | Dec 31, 2023 | 0M | +452.1% |
| FY2022 | Dec 31, 2022 | 0M | +151.8% |
| FY2021 | Dec 31, 2021 | 0M | +56.0% |
| FY2020 | Dec 31, 2020 | 0M | -0.2% |
| FY2019 | Dec 31, 2019 | 0M | +45.1% |
| FY2018 | Dec 31, 2018 | 0M | +29.1% |
| FY2017 | Dec 31, 2017 | 0M | +3.5% |
| FY2016 | Dec 31, 2016 | 0M | +32.2% |
| FY2015 | Dec 31, 2015 | 0M | +90.4% |
| FY2014 | Dec 31, 2014 | 0M | +199.2% |
| FY2012 | Oct 31, 2012 | 0M | 0.0% |
| FY2011 | Oct 31, 2011 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 4M | +108.2% |
| Q2 FY2026 | Jun 30, 2026 | 2M | +222.1% |
| Q1 FY2026 | Mar 31, 2026 | 2M | +238.3% |
| Q4 FY2025 | Dec 31, 2025 | 2M | +335.9% |
| Q3 FY2025 | Sep 30, 2025 | 2M | +514.1% |
| Q2 FY2025 | Jun 30, 2025 | 1M | +186.3% |
| Q1 FY2025 | Mar 31, 2025 | 1M | -19.7% |
| Q4 FY2024 | Dec 31, 2024 | 0M | -9.9% |
| Q3 FY2024 | Sep 30, 2024 | 0M | -25.4% |
| Q2 FY2024 | Jun 30, 2024 | 0M | -42.6% |
| Q1 FY2024 | Mar 31, 2024 | 1M | +883.4% |
| Q4 FY2023 | Dec 31, 2023 | 0M | +964.3% |
| Q3 FY2023 | Sep 30, 2023 | 0M | +808.6% |
| Q2 FY2023 | Jun 30, 2023 | 0M | +2697.0% |
| Q1 FY2023 | Mar 31, 2023 | 0M | +454.0% |
| Q2 FY2022 | Jun 30, 2022 | 0M | +255.5% |
| Q1 FY2022 | Mar 31, 2022 | 0M | +255.5% |
| Q3 FY2021 | Sep 30, 2021 | 0M | 0.0% |
| Q2 FY2021 | Jun 30, 2021 | 0M | 0.0% |
| Q1 FY2021 | Mar 31, 2021 | 0M | 0.0% |
| Q4 FY2020 | Dec 31, 2020 | 0M | +0.0% |
| Q3 FY2020 | Sep 30, 2020 | 0M | -0.2% |
| Q2 FY2020 | Jun 30, 2020 | 0M | -0.3% |
| Q1 FY2020 | Mar 31, 2020 | 0M | -0.3% |
| Q4 FY2019 | Dec 31, 2019 | 0M | +86.3% |
| Q3 FY2019 | Sep 30, 2019 | 0M | -1.4% |
| Q2 FY2019 | Jun 30, 2019 | 0M | +65.1% |
| Q1 FY2019 | Mar 31, 2019 | 0M | +67.9% |
| Q4 FY2018 | Dec 31, 2018 | 0M | -0.2% |
| Q3 FY2018 | Sep 30, 2018 | 0M | +90.1% |
| Q2 FY2018 | Jun 30, 2018 | 0M | +8.5% |
| Q1 FY2018 | Mar 31, 2018 | 0M | +12.0% |
| Q4 FY2017 | Dec 31, 2017 | 0M | +0.8% |
| Q3 FY2017 | Sep 30, 2017 | 0M | +0.2% |
| Q2 FY2017 | Jun 30, 2017 | 0M | – |
| Q1 FY2017 | Mar 31, 2017 | 0M | – |
| Q4 FY2016 | Dec 31, 2016 | 0M | – |
| Q3 FY2016 | Sep 30, 2016 | 0M | – |
See a number that looks wrong?